7039-74-9 Usage
General Description
2-BROMO-1-(5-CHLORO-1-BENZOFURAN-2-YL)ETHANONE is a chemical compound with the molecular formula C10H6BrClO2. It is an organic compound that contains a benzofuran ring, a bromine atom, and a chlorine atom. 2-BROMO-1-(5-CHLORO-1-BENZOFURAN-2-YL)ETHANONE is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also employed in organic chemistry reactions, such as the synthesis of heterocyclic compounds. Additionally, it has been studied for its potential pharmacological and biological activities, including its antitumor and anti-inflammatory properties. The compound has a melting point of 97-98°C and is typically stored and handled in accordance with standard laboratory procedures for organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 7039-74-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,0,3 and 9 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 7039-74:
(6*7)+(5*0)+(4*3)+(3*9)+(2*7)+(1*4)=99
99 % 10 = 9
So 7039-74-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H6BrClO2/c11-5-8(13)10-4-6-3-7(12)1-2-9(6)14-10/h1-4H,5H2
7039-74-9Relevant articles and documents
Synthesis and Anti-Cholinesterase Activity of Novel Glycosyl Benzofuranylthiazole Derivatives
Cao, L.,Cao, Zh.,Chen, Ch.,Jiang, K.,Liu, Sh.,Liu, W.,Lu, X.,Shao, Zh.,Shi, D.,Su, Z.,Wang, L.,Wang, Y.,Wu, Y.
, p. 1513 - 1518 (2021/10/26)
Abstract: A new series of glycosyl benzofuranylthiazole derivatives were designed, synthesized, characterized, and evaluated as potential candidates to treat Alzheimer’s disease. The compounds have been synthesized by the cyclocondensation of glycosyl thiourea with a variety of 2-(bromoacetyl)benzofurans. The reaction conditions have been optimized, and good yields (79–95%) have been obtained. The synthesized compounds showed different degrees of cholinesterase inhibitory activity.
OXADIAZINE COMPOUNDS AND METHODS OF USE THEREOF
-
, (2016/12/26)
The present disclosure relates to oxadiazine compounds, pharmaceutical compositions comprising an effective amount of an oxadiazine compound and methods for using an oxadiazine compound in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of an oxadiazine compound.
